SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments
- PMID: 21706386
- DOI: 10.1007/s00335-011-9339-1
SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease with no cure. Breakthroughs in understanding ALS pathogenesis came with the discovery of dominant mutations in the superoxide dismutase 1 gene (SOD1) and other genes, including the gene encoding transactivating response element DNA binding protein-43 (TDP-43). This has led to the creation of animal models to further our understanding of the disease and identify a number of ALS-causing mechanisms, including mitochondrial dysfunction, protein misfolding and aggregation, oxidative damage, neuronal excitotoxicity, non-cell autonomous effects and neuroinflammation, axonal transport defects, neurotrophin depletion, effects from extracellular mutant SOD1, and aberrant RNA processing. Here we summarise the SOD1 and TDP-43 animal models created to date, report on recent findings supporting the potential mechanisms of ALS pathogenesis, and correlate this understanding with current developments in the clinic.
Similar articles
-
TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase.Neurochem Int. 2010 Dec;57(8):906-13. doi: 10.1016/j.neuint.2010.09.010. Epub 2010 Oct 7. Neurochem Int. 2010. PMID: 20933032
-
ALS pathogenesis: recent insights from genetics and mouse models.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):363-9. doi: 10.1016/j.pnpbp.2010.08.006. Epub 2010 Aug 20. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 20728492
-
Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.Mol Neurobiol. 2019 Mar;56(3):2007-2021. doi: 10.1007/s12035-018-1218-2. Epub 2018 Jul 7. Mol Neurobiol. 2019. PMID: 29982983 Free PMC article.
-
Using yeast models to probe the molecular basis of amyotrophic lateral sclerosis.Biochem Soc Trans. 2011 Oct;39(5):1482-7. doi: 10.1042/BST0391482. Biochem Soc Trans. 2011. PMID: 21936838 Review.
-
Protein misdirection inside and outside motor neurons in Amyotrophic Lateral Sclerosis (ALS): a possible clue for therapeutic strategies.Int J Mol Sci. 2011;12(10):6980-7003. doi: 10.3390/ijms12106980. Epub 2011 Oct 19. Int J Mol Sci. 2011. PMID: 22072931 Free PMC article. Review.
Cited by
-
Genetics of amyotrophic lateral sclerosis: an update.Mol Neurodegener. 2013 Aug 13;8:28. doi: 10.1186/1750-1326-8-28. Mol Neurodegener. 2013. PMID: 23941283 Free PMC article. Review.
-
The Proline/Arginine Dipeptide from Hexanucleotide Repeat Expanded C9ORF72 Inhibits the Proteasome.eNeuro. 2017 Jan 31;4(1):ENEURO.0249-16.2017. doi: 10.1523/ENEURO.0249-16.2017. eCollection 2017 Jan-Feb. eNeuro. 2017. PMID: 28197542 Free PMC article.
-
Vapb/Amyotrophic lateral sclerosis 8 knock-in mice display slowly progressive motor behavior defects accompanying ER stress and autophagic response.Hum Mol Genet. 2015 Nov 15;24(22):6515-29. doi: 10.1093/hmg/ddv360. Epub 2015 Sep 11. Hum Mol Genet. 2015. PMID: 26362257 Free PMC article.
-
Inflammatory-Mediated Neuron-Glia Communication Modulates ALS Pathophysiology.J Neurosci. 2021 Feb 10;41(6):1142-1144. doi: 10.1523/JNEUROSCI.1970-20.2020. J Neurosci. 2021. PMID: 33568447 Free PMC article. No abstract available.
-
Dysregulated mitochondrial Ca2+ and ROS signaling in skeletal muscle of ALS mouse model.Arch Biochem Biophys. 2019 Mar 15;663:249-258. doi: 10.1016/j.abb.2019.01.024. Epub 2019 Jan 22. Arch Biochem Biophys. 2019. PMID: 30682329 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous